Share:
Former Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna™, to lead development of SparingVision s proprietary asset, SPVN06, and further pipeline development
Paris, February 04, 2021 – SparingVision (the Company ), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the appointment of Dr Daniel C. Chung as Chief Medical Officer ( CMO ). Dr Chung brings a wealth of experience in successful ocular gene therapy development, having led the global medical strategy for ophthalmology at Spark Therapeutics ( Spark ), a leading rare disease gene therapy company, where he played a pivotal role in the clinical development and approval of Luxturna™, the first gene therapy to be approved in the US for a genetic disease. Spark was acquired by Roche in 2019 for $4.3 billion.
Renowned Pioneers in Ophthalmology Join SparingVision s Scientific Advisory Board
Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board
Paris, January 29, 2021 - SparingVision (the Company ), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the strengthening of its Scientific Advisory Board ( SAB ) with the appointment of internationally renowned ophthalmology pioneers Dr. Paul A. Sieving, Professor of University of California Davis School of Medicine and the former Director of the US National Eye Institute, and Prof. Botond Roska, co-director of the Institute of Molecular and Clinical Ophthalmology Basel and Professor at the Medical and Science Faculty of the University of Basel.
Share this article
Share this article
COLUMBIA, Md., Jan. 26, 2021 /PRNewswire/ The Foundation Fighting Blindness, the world s leading organization committed to finding treatments and cures for blinding retinal diseases, presents its first-ever virtual gala,
Hope from Home:
A United Night to Save Sight, hosted by Saturday Night Live alum,
Kevin Nealon. Taking place on Sunday, February 28 at 7 p.m. ET, guests will experience a virtual party packed with comedy, inspiration, and special music performances – all from the comfort of their homes.
This event, kicking off the Foundation s 50
th anniversary, will feature entertainment from award-nominated recording artist,
Charlie Kramer, silent and live auctions, and the opportunity to explore different party rooms with activities, including tastings, music, games, sports, and health and wellness. During the event, the Foundation will present the Llura Liggett Gund Award – the Foundation s highest research award honoring
Published January 18. 2021 5:08PM | Updated January 19. 2021 9:22AM
Ledyard Sofia Sees Hope, a locally based nonprofit, will donate $72,000 to support research into treatments for inherited retinal diseases and to provide free access to genetic testing for those with IRDs.
The coronavirus pandemic last year forced the organization to cancel its main fundraising event, Dinner in the Dark, a well-attended dinner that has raised nearly $200,000 in previous years.
“We’re grateful that we still had a pretty successful year,” Laura Manfre, the organization’s co-founder and board president, said in a news release. “The global pandemic made fundraising challenging for all nonprofits, but we were able to pivot with the help of our terrific team, made up of staff, volunteers and our board of directors. This allowed us to continue our commitment to funding research into treatments for inherited retinal disease.”
Courtesy of BridgePoint
Ron and Jeannie Yeargin persevere through blindness and COVID-19, staying active and looking at the bright side of life.
Ron and Jeannie Yeargin got more than they bargained for when they began a new chapter in their life at BridgePoint at Los Altos.
They moved into their apartment Feb. 25, and were enjoying settling in and meeting their new neighbors. But on March 13 (Friday the 13th, she noted), Jeannie was taken to the hospital with a high fever.
The doctors sent her home to BridgePoint, thinking she might have a bladder infection. When the test results came back, however, it was worse than that: